- CD73 INHIBITORS
-
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases.
- -
-
Paragraph 0247
(2021/02/12)
-
- PYRROLOTRIAZINE KINASE INHIBITORS
-
The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of such as TrkA, TrkB, TrkC, Jak2, Jak3 and CK2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.
- -
-
Page/Page column 40
(2008/06/13)
-
